These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34226639)

  • 1. Characterizing the differences between multisystem inflammatory syndrome in children and Kawasaki disease.
    Bar-Meir M; Guri A; Godfrey ME; Shack AR; Hashkes PJ; Goldzweig O; Megged O
    Sci Rep; 2021 Jul; 11(1):13840. PubMed ID: 34226639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
    Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis.
    Mohsin SS; Abbas Q; Chowdhary D; Khalid F; Sheikh AS; Ali Khan ZG; Aslam N; Bhatti OA; Inam M; Saleem AF; Bhutta AT
    PLoS One; 2021; 16(6):e0253625. PubMed ID: 34153080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
    Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
    J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
    Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
    Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
    Front Immunol; 2021; 12():632890. PubMed ID: 33732254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome.
    Godfred-Cato S; Abrams JY; Balachandran N; Jaggi P; Jones K; Rostad CA; Lu AT; Fan L; Jabbar A; Anderson EJ; Kao CM; Hunstad DA; Rosenberg RB; Zafferani MJ; Ede KC; Ballan W; Laham FR; Beltran Y; Bryant B; Meng L; Hammett TA; Oster ME; Bamrah Morris S; Belay ED
    Pediatr Infect Dis J; 2022 Apr; 41(4):315-323. PubMed ID: 35093995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group.
    Yilmaz Ciftdogan D; Ekemen Keles Y; Cetin BS; Dalgic Karabulut N; Emiroglu M; Bagci Z; Buyukcam A; Erdeniz EH; Arga G; Yesil E; Cakici O; Karbuz A; Sahbudak Bal Z; Kara SS; Ozer A; Metin Akcan O; Elmas Bozdemir S; Anil AB; Uygun H; Kilic O; Hancerli Torun S; Umit Z; Sutcu M; Ozgokce Ozmen B; Karaoglu Asrak H; Alkan G; Kara Aksay A; Ugur C; Birbilen AZ; Bursal Duramaz B; Akyuz Ozkan E; Burakay O; Yildirim Arslan S; Karadag Oncel E; Celik SF; Kilic AO; Ozen S; Sarikaya R; Demirkol D; Arslan G; Turel O; Sert A; Sari E; Orbak Z; Sahin IO; Varan C; Akturk H; Tuter Oz SK; Durak F; Oflaz MB; Kara M; Karpuz D; Talip Petmezci M; Hatipoglu N; Oncel S; Turgut M; Elmali F; Somer A; Kuyucu N; Dinleyici EC; Kurugöl Z; Ciftci E; Kara A
    Eur J Pediatr; 2022 May; 181(5):2031-2043. PubMed ID: 35129668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic.
    Alkan F; Bircan O; Bal A; Bayturan S; Zengin N; Coskun S
    BMC Pediatr; 2024 Jul; 24(1):485. PubMed ID: 39080588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
    Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
    Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.
    Yamaguchi Y; Takasawa K; Irabu H; Hiratoko K; Ichigi Y; Hirata K; Tamura Y; Murakoshi M; Yamashita M; Nakatani H; Shimoda M; Ishii T; Udagawa T; Shimizu M; Kanegane H; Morio T
    J Infect Chemother; 2022 Jun; 28(6):814-818. PubMed ID: 35125343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
    Noval Rivas M; Arditi M
    Rheum Dis Clin North Am; 2023 Aug; 49(3):647-659. PubMed ID: 37331738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine profile.
    Fukuda S; Kaneta M; Miyake M; Ohya T; Miyakawa K; Iwamoto M; Ito S
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):442-447. PubMed ID: 33904379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Multisystemic Inflammatory Syndrome Temporarily associated with COVID-19: Clinical characteristics and management in a Pediatric Critical Care Unit.
    Yagnam R F; Izquierdo C G; Villena M R; González M C; Drago-T M
    Andes Pediatr; 2021 Jun; 92(3):395-405. PubMed ID: 34479246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Laboratory Characteristics of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children.
    Phi DL; Dao TL; To MM; Nguyen TB; Nguyen DC; Gautret P; Hoang VT
    J Korean Med Sci; 2023 Dec; 38(49):e410. PubMed ID: 38111281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children.
    Plebani A; Meini A; Cattalini M; Lougaris V; Bugatti A; Caccuri F; Caruso A
    Clin Immunol; 2020 Dec; 221():108613. PubMed ID: 33069853
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric Inflammatory Multisystem Syndrome: Time to Collaborate.
    Kanthimathinathan HK; Scholefield BR
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):227-229. PubMed ID: 32945863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.